Skip to content
Contract signedUnited KingdomServices

Send Away Test for Oncotype DX Breast Recurrence Score

Published
Published 3 February 2026

Overview

Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer.

Key details

Country
United Kingdom
Status
Contract signed
Category
Services
Procedure
Limited
Published
3 February 2026
Classification (CPV)
Pathology services

Award outcome

Awarded value
£214,650
Award date
3 February 2026
Winner
  • Exact Sciences UK, Ltd.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract

    3 February 2026

    View notice ↗

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Send Away Test for Oncotype DX Breast Recurrence Score — won by Exact Sciences UK, Ltd. — Skim